A carregar...
PARP抑制剂在小细胞肺癌的研究进展
Small cell lung cancer (SCLC), characterized by early metastasis, relapse, relapse and resistance and poor prognosis, still faces difficulties in treatment. Recently, Immunotherapy is a novel treatment for SCLC, researchers are also eager to achieve a breakthrough in targeted treatment of SCLC. Geno...
Na minha lista:
| Publicado no: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
中国肺癌杂志编辑部
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7519958/ https://ncbi.nlm.nih.gov/pubmed/32752582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.19 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|